Publications

Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory.

Palekyte, A; Morkowska, A; Billington, O; Morris-Jones, S; Millard, J; Marakalala, MJ; Owolabi, O; Sambou, B; Zumla, A; SUTHERLAND, JS; McHugh, TD; Honeyborne, I;

2024

Clinical chemistry, (2024).70 4 10.1093/clinchem/hvae013.

Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning.

CRyPTIC consortium,;

2024

PLoS computational biology, (2024).20 8 10.1371/journal.pcbi.1012260.

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

James, LP; Klaassen, F; SWEENEY, S; Furin, J; Franke, MF; Yaesoubi, R; Chesov, D; Ciobanu, N; Codreanu, A; Crudu, V; Cohen, T; Menzies, NA;

2024

PLoS medicine, (2024).21 5 10.1371/journal.pmed.1004401.

Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: an epidemiological analysis of historical data.

MacPherson, P; STAGG, H; SCHWALB, A; Henderson, H; Taylor, A; BURKE, R; Rickman, H; Miller, C; Houben, R; Dodd, P; Corbett, EL;

2024

PLoS medicine, (2024).21 11 10.1371/journal.pmed.1004448.

Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.

RICKMAN, HM; Phiri, MD; Feasey, HR A; Mbale, H; Nliwasa, M; Semphere, R; Chagaluka, G; FIELDING, K; Mwandumba, HC; HORTON, KC; NIGHTINGALE, ES; Henrion, MY R; Mbendera, K; Mpunga, JA; CORBETT, EL; MacPherson, P;

2024

PloS one, (2024).19 5 10.1371/journal.pone.0291215.

Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study.

Ryckman, TS; MCQUAID, CF; Cohen, T; Menzies, NA; Kendall, EA;

2024

The Lancet Global health, (2024).12 10 10.1016/S2214-109X(24)00284-5.

Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.

Paulowski, L; Filip, R; Jankovic Makek, M; Guglielmetti, L; Goletti, D; Van Ingen, J; KRANZER, K; Maurer, FP; ESGMYC,;

2024

PloS One, (2024).19 4 10.1371/journal.pone.0291404.

Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: an epidemiological analysis of historical data.

MacPherson, P; Stagg, HR; SCHWALB, A; Henderson, H; Taylor, A; BURKE, RM; RICKMAN, HM; Miller, C; HOUBEN, RM G J; Dodd, PJ; CORBETT, EL;

2024

PLoS Medicine, (2024).21 11 10.1371/journal.pmed.1004448.

Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.

Kho, S; Seung, KJ; Huerga, H; Bastard, M; KHAN, PY; Mitnick, CD; Rich, ML; Islam, S; Zhizhilashvili, D; Yeghiazaryan, L; Nikolenko, EN; Zarli, K; Adnan, S; Salahuddin, N; Ahmed, S; Vargas, ZH R; Bekele, A; Shaimerdenova, A; Tamirat, M; Gelin, A; Vilbrun, SC; Hewison, C; Khan, U; Franke, M;

2024

Nature communications, (2024).15 1 10.1038/s41467-024-48077-8.

Household contact management and preventive treatment for drug-resistant tuberculosis.

Seddon, JA; MCQUAID, CF; Mafirakureva, N; Hesseling, AC; Fox, GJ; Dodd, PJ;

2024

The Lancet. Global health, (2024).12 9 10.1016/s2214-109x(24)00265-1.